WeVote

Bill

Bill

LB 762

Require insurance coverage of pediatric autoimmune disorders

109th Legislature (2025-2026) Introduced by Tom Brandt and 13 co-sponsors

Nebraska bill mandates health insurance coverage for pediatric autoimmune disorder treatments to improve access for affected children and reduce family financial burden.

Presented to Governor on April 10, 2026
0
WeVote Research Nonpartisan
Bill Summary · LB 762

Legislative bill overview

LB 762 would mandate that health insurance plans in Nebraska provide coverage for the treatment of pediatric autoimmune disorders. The bill requires insurers to include these conditions within their standard coverage requirements, potentially removing insurance barriers to care for affected children.

Why is this important

Pediatric autoimmune disorders—such as PANDAS (Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections) and other autoimmune conditions—can cause severe developmental and behavioral complications if left untreated. Insurance coverage mandates directly affect families' ability to access specialized treatments, which may otherwise be cost-prohibitive and create financial hardship while children face critical developmental windows.

Potential points of contention

  • Medical consensus uncertainty: Some pediatric autoimmune conditions lack broad clinical consensus on treatment protocols, creating debate over what should be "required" coverage versus investigational care
  • Insurance cost implications: Mandatory coverage requirements increase premiums across the market; insurers and employers may resist based on actuarial impact concerns
  • Definition scope: The bill's specificity regarding which autoimmune disorders qualify could be contentious—overly narrow definitions exclude families while overly broad ones create implementation challenges

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.